Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-6-3
pubmed:abstractText
Bisphenol A (BPA) is a monomer use in manufacturing a wide range of chemical products which include epoxy resins and polycarbonate. It has been reported that BPA increases the cell proliferation activity of human breast cancer MCF-7 cells as well as 17-beta estradiol (E2) and diethylstilbestrol (DES). However, BPA induces target genes through ER-dependent and ER-independent manners which are different from the actions induced by E2. Therefore, BPA may be unique in estrogen-dependent cell proliferation compared to other endocrine disrupting chemicals (EDCs). In the present study, to test whether ERalpha is essential to the BPA-induced proliferation on MCF-7 cells, we suppressed the ERalpha expression of MCF-7 cells by RNA interference (RNAi). Proliferation effects in the presence of E2, DES and BPA were not observed in ERalpha-knockdown MCF-7 cells in comparison with control MCF-7. In addition, a marker of proliferative potential, MIB-1 labeling index (LI), showed no change in BPA-treated groups compared with vehicle-treated groups on ERalpha-knockdown MCF-7 cells. In conclusion, we demonstrated that ERalpha has a role in BPA-induced cell proliferation as well as E2 and DES. Moreover, this study indicated that the direct knockdown of ERalpha using RNAi serves as an additional tool to evaluate, in parallel with MCF-7 cell proliferation assay, for potential EDCs.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-10397975, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-10724352, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-11258963, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-11552294, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-11566753, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-11581496, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-11959843, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-12065211, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-12402979, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-14993442, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-15223131, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-16029874, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-17375206, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-17460769, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-17628395, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-2829071, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-3609543, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-7193511, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-7556016, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-7723797, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-8504731, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-8593856, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-8770893, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-9074884, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-9347895, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-9449681, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-9495200, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-9783916, http://linkedlifedata.com/resource/pubmed/commentcorrection/19492024-9829047
pubmed:language
eng
pubmed:journal
pubmed:status
PubMed-not-MEDLINE
pubmed:month
Apr
pubmed:issn
0044-5991
pubmed:author
pubmed:issnType
Print
pubmed:day
28
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
23-8
pubmed:dateRevised
2009-11-18
pubmed:year
2009
pubmed:articleTitle
The influence of endocrine disrupting chemicals on the proliferation of ERalpha knockdown-human breast cancer cell line MCF-7; new attempts by RNAi technology.
pubmed:affiliation
Department of Pathology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan.
pubmed:publicationType
Journal Article